INC280 (capmatinib)

capmatinib · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INC280 (capmatinib), covering 2016-09-01 to 2016-09-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma [Phase 2]